Penumbra has secured CE-mark approval for its SwiftPAC neuroembolisation coil, which is part of the company’s Swift coil system. SwiftPAC coils are now commercially available in Europe, according to a recent Penumbra press release.
The company’s SwiftPAC coils are designed as a soft, space-seeking ‘liquid metal’ that conforms to the target vessel to achieve dense packing. Penumbra claims that these attributes provide versatility across a variety of clinical applications, including the treatment of intracranial aneurysms, chronic subdural haematomas (cSDHs), carotid cavernous fistulas (CCFs) and a number of other neurovascular conditions.
“The shapeless design of the new SwiftPAC coil allows for efficient, dense occlusion of the MMA [middle meningeal artery] branches in awake patients and the essential control to avoid dangerous anastomoses,” said Johannes Hensler (University Hospital Schleswig-Holstein, Kiel, Germany).
The innovative 2D sinusoidal shape of the device is designed to help the coil break “effortlessly” in order to seek empty space, according to Penumbra, with the company also stating that SwiftPAC is “one of the softest 10-system coils on the market”, with a softness value of 0.093.
SwiftPAC coils offer physicians the ability to deploy and reposition with precision before detaching, Penumbra’s release adds.
The device has a 0.0135-inch primary diameter deliverable through 0.0165-inch microcatheters, and is available in a range of lengths from 3cm to 60cm—characteristics intended to optimise embolisation across different vessel sizes and anatomies.
Earlier this year, in June, Penumbra announced the expansion of its SwiftPAC product offering to include 20cm and 25cm coils, with the goal of helping physicians to meet the growing demand for the endovascular treatment of neurosurgical conditions.
“SwiftPAC advances embolisation by offering both occlusion efficiency and precision—two essential factors in meeting the growing demand for neurovascular procedures extending beyond MMA embolisation,” commented Adi Iyer (Providence Saint Joseph Medical Center, Burbank, USA).
